Podcast appearances and mentions of brent saunders

Cathleen McCabe, MD, and Brent Saunders, chairman and CEO of Bausch + Lomb, join the podcast to break down details of the recent voluntary recall of enVista Aspire, enVista Envy, and certain enVista monofocal IOLs. Hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite discussion on how the Bausch + Lomb team identified an issue, prioritized patient safety, and dove into the data to bring this innovative technology back to patients as quickly and safely as possible.

In the latest episode of Skin in the Game VC, Tom Wallace and Saxon Baum welcomed Brent Saunders, Chairman and CEO of Bausch & Lomb, to share his journey and insights into leadership, healthcare innovation, and the power of investing in groundbreaking ideas. From his early days as student body president at the University of Pittsburgh to overseeing multi-billion-dollar deals in the healthcare industry, Brent's career is a masterclass in strategic thinking and execution.Brent reflected on his experience leading companies like Allergan and Bausch & Lomb, where he navigated complex mergers and acquisitions totaling nearly $300 billion. His approach centers on aligning deals with a strong strategic rationale and financial discipline, ensuring long-term value creation rather than short-term gains.A recurring theme throughout the conversation was Brent's passion for leveraging technology to tackle inefficiencies in healthcare. He highlighted the potential of AI to transform drug discovery and streamline clinical trials, sharing how his company uses AI to identify solutions for challenging diseases. Brent also emphasized the need for universal, portable medical records to improve patient outcomes and reduce systemic inefficiencies—a vision that remains elusive but vital for the future.As an active investor, Brent shared his enthusiasm for backing startups that prioritize innovation and have strong, experienced teams. He cited Roam, a Miami-based tech startup led by Howard Lerman, as an example of a company combining cutting-edge ideas with proven leadership. Brent underscored the value of working with founders who have “climbed the hill before,” noting that their experience and resilience often set them apart.Looking to the future, Brent offered predictions on market trends, including the growing influence of AI and the expected resurgence in mergers and acquisitions as regulatory conditions evolve. His optimism about technological advancements was balanced by a thoughtful caution regarding overuse in areas like pharmaceuticals, emphasizing the importance of weighing benefits against risks.The episode was not just a window into Brent's accomplishments but also a reminder of the power of innovation, the importance of adaptability, and the need to continually refine one's craft. For anyone navigating the intersection of technology, business, and leadership, Brent's insights provide both inspiration and actionable guidance. Be sure to tune in to Skin in the Game VC for more conversations with trailblazing leaders and investors shaping the future. Hosted on Acast. See acast.com/privacy for more information.

In this episode, we're joined by the legendary Brent Saunders. Brent Saunders is a world-renowned Fortune 500 CEO who has completed more than $300 billion in mergers & acquisitions throughout his career. He is the CEO of Bausch + Lomb, Chairman of Roam, and former CEO of Allergan, which he sold to AbbVie for $83 billion. He is a pioneer in the health & beauty industry and is directly responsible for building some of the biggest consumer brands, including Botox, Claritin, and Coppertone.This is not just a conversation; it's a masterclass in leadership, strategy, and the skills required to steer a global pharmaceutical giant.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Julia Haller, MD, about the latest developments in retina, residency training and more. Welcome to the Eyeluminaries podcast :01 Review of episode 17, live from Octane OTF :41 Bausch + Lomb makes a number of big moves under the new Brent Saunders regime 1:40 Mark Baum and Harrow Health have also been making a number of acquisitions 3:59 FDA approves Xdemvy for Demodex blepharitis treatment 5:45 Former CEO of Johnson & Johnson Alex Gorsky elected lead director of Neurotech's board 7:47 John begins new clinical committee for ASCRS, digital 9:32 Julia Haller, MD introduction 11:30 ReST Committee update on intraocular inflammation reported in patients who received Syfovre at the American Society of Retina Specialists annual meeting 13:44 The FDA approved Izervay for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Astellas Pharma 14:16 Novartis is discontinuing the development of GT005 for the treatment of geographic atrophy secondary to dry age-related macular degeneration 14:36 How has the latest retina news affected patients and physicians? 14:53 The development of biosimilars 19:50 Discussion on pricing of products 21:57 The evolution and future of residency programs 23:34 Fun with retina drug names 27:15 Preview of episode 19 at OSN New York 29:46 Feedback, questions and guest suggestions at eyeluminaries@healio.com 30:15 Thanks for listening 30:27 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Julia Haller, MD, is Ophthalmologist-in-Chief and William Tasman, MD Endowed Chair at Wills Eye Hospital and Professor and Chair of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Haller reports being on the board of directors at Bristol Myers Squibb, Opthea and Outlook Therapeutics. She is consultant to Aura Biosciences, Bionic Sight, Lowy Medical Research Institute and Regeneron.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at OCTANe OTS with Mark Leahey, Brent Saunders, Yari Mitchell and Robert Dempsey, discussing their experiences and influence across the ophthalmic space. ·       Welcome to the Eyeluminaries podcast :01 ·       Review of episode 16 with Stephen McLeod, MD :28 ·       Preview of episode 17, live at Octane OTS 1:00 ·       Introduce Mark Leahey, president & CEO for the Medical Device Manufacturers Association 1:23 ·       Challenges in medical device 2:19 ·       Is it possible for the government to reduce regulation of medical devices while still protecting patients? 4:32 ·       What is MDMA doing for sustainability? 6:50 ·       What is one issue that device manufacturers need to implement? 9:04 ·       Introduce Brent Saunders, Chairman and CEO of Bausch + Lomb 12:23 ·       What's different about Bausch + Lomb today that wasn't around when you first worked for the company? 13:27 ·       Tell us about other products at Bausch + Lomb. 19:22 ·       Introducing Yari Mitchell, the president of Y Factor Consulting, Inc. 23:31 ·       What have been the most important changes in the ophthalmic industry over the past couple of years? 24:58 ·       What advice would you give to an early-career person? 26:15 ·       Favorite memories of Jim Mazzo 29:14 ·       Introducing Robert Dempsey, CEO and President of AsclepiX Therapeutics 32:10 ·       What was it like to leap from medical sciences to a leadership position? 33:22 ·       Managing a pipeline that includes both retinal and cornea treatments 35:05 ·       How do you establish yourself as a competitor in age-related macular degeneration research in a mature and crowded market with limited resources? 36:10 ·       Creating a retinal treatment delivered via the suprachoroidal route 37:28 ·       The Holland Foundation For Sight Restoration seeking to spread access to eye care for patients and the importance of giving back 38:27 ·       Feedback, questions and guest suggestions at eyeluminaries@healio.com 44:00 ·       Thanks for listening 44:19 Robert Dempsey is the CEO and president of AsclepiX Therapeutics. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO of the Medical Device Manufacturers Association. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Yari Mitchell is the president of Y Factor Consulting, Inc. Brent Saunders is the chairman and CEO of Bausch + Lomb. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Dempsey is the president and CEO of AsclepiX Therapeutics. Hovanesian consults widely in the ophthalmic field. Leahey is the president & CEO for the Medical Device Manufacturers Association. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Mitchell is the chief business development officer at AcuFocus and the president of Y Factor Consulting, Inc. Saunders is the chairman and CEO of Bausch + Lomb.

The averages fell after the Fed announced it would raise interest rates by 0.25% and Jim Cramer is helping investors navigate a market impacted by the FOMC's policy change. First, Cramer's biting into Brinker International's most recent quarter with CEO Kevin Hochman. Then, should investors keep an eye on Bausch + Lomb? Cramer's talking to CEO Brent Saunders. Plus, Cramer's exclusive with Wingstop CEO Michael Skipworth. Mad Money Disclaimer

Blake Williamson, MD, MPH, and Gary Wörtz, MD, continue this season's theme of how to grow a business and welcome Brent Saunders, chairman and CEO of Bausch + Lomb, to discuss his experiences in ophthalmology. Mr. Saunders touches on how he defines business success, emphasizing the value of having a great mentor and encouraging young ophthalmologists not to shy away from taking risks. 

We are proud to present a very special episode featuring BeautyHealth Executive Chairman Brent Saunders, recorded live at AIS 2022. Best known in the aesthetic world as the former Chairman/President/CEO of Allergan, Brent's impressive leadership resume includes PwC, Bausch + Lomb, and Cisco (not to mention his $1.1 billion SPAC deal to take HydraFacial public in 2021). In this Keynote Interview conducted by Dr. Grant Stevens, find out what Brent forecasts for the future of aesthetics, along with talk of acquisitions and pandemic economics, incremental vs. actual innovation, enthusiasm for new technologies, why aesthetic consumers are more discerning than others, and much more — all in the next episode of the Technology of Beauty.

Today we've got Brent Saunders, CEO of Vesper Healthcare Acquisition Corp and former CEO of Allergan, on the podcast to talk about current market conditions and what COVID has been like in Miami. Then we're discussing the Chiefs' victory over the Bills, the jump in return rates for retailers, the announced changes to the SATs, and finally a bonus interview with Ian Rogers, Chief Experience Officer of Ledger. Holy NFL – Group Chat News 1.25.22 A Group Chat exclusive interview with Brent Saunders, CEO of Vesper Healthcare Acquisition Corp and former CEO of Allergan. They discuss the current market conditions, and what COVID has been like in Miami in comparison to the rest of the country. [1:36] Holy NFL!! [42:15] The problems with returns. [51:57] What took so long for the SATs to change?! [57:00] A Group Chat exclusive interview with Ian Rogers, Chief Experience Officer of Ledger. They discuss his addiction to NFTs, what is going on in crypto, Ledger's recent collaboration with Fendi, addressing safety concerns, and predicting the future of crypto for 2022. [1:10:44] Related Links/Products Mentioned 42.7 million people watched the Kansas City Chiefs' thrilling win over Buffalo Bills A more than $761 billion dilemma: Retailers' returns jump as online sales grow SAT changes will make exam shorter, simpler, and digital objkt.com | The largest NFT marketplace on Tezos fx(hash) - Art Is Evolving - An NFT Platform That Enables You To Launch A Generative Art Series On Tezos Fendi teams up with Ledger for luxury crypto hardware wallet accessories OpenSea reportedly hacked for $780,000 Connect with Group Chat! Watch The Pod #1 Newsletter In The World For The Gram Tweet With Us Exclusive Facebook Content

Today we've got Brent Saunders, CEO of Vesper Healthcare Acquisition Corp and former CEO of Allergan, on the podcast to talk about current market conditions and what COVID has been like in Miami. Then we're discussing the Chiefs' victory over the Bills, the jump in return rates for retailers, the announced changes to the SATs, and finally a bonus interview with Ian Rogers, Chief Experience Officer of Ledger. Holy NFL – Group Chat News 1.25.22 A Group Chat exclusive interview with Brent Saunders, CEO of Vesper Healthcare Acquisition Corp and former CEO of Allergan. They discuss the current market conditions, and what COVID has been like in Miami in comparison to the rest of the country. [1:36] Holy NFL!! [42:15] The problems with returns. [51:57] What took so long for the SATs to change?! [57:00] A Group Chat exclusive interview with Ian Rogers, Chief Experience Officer of Ledger. They discuss his addiction to NFTs, what is going on in crypto, Ledger's recent collaboration with Fendi, addressing safety concerns, and predicting the future of crypto for 2022. [1:10:44] Related Links/Products Mentioned 42.7 million people watched the Kansas City Chiefs' thrilling win over Buffalo Bills A more than $761 billion dilemma: Retailers' returns jump as online sales grow SAT changes will make exam shorter, simpler, and digital objkt.com | The largest NFT marketplace on Tezos fx(hash) - Art Is Evolving - An NFT Platform That Enables You To Launch A Generative Art Series On Tezos Fendi teams up with Ledger for luxury crypto hardware wallet accessories OpenSea reportedly hacked for $780,000 Connect with Group Chat! Watch The Pod #1 Newsletter In The World For The Gram Tweet With Us Exclusive Facebook Content

Brent Saunders is currently Chairman of Vesper Healthcare and former Chairman, President and Chief Executive Officer of Allergan plc. Brent has been involved and contributed a great deal to many of the household brands we know today. On today's episode Marc and Brent discuss great leadership skills, being passionate about what you do and how consistent hard work does not equal LUCK!

Brent Saunders is the CEO of Vesper Healthcare Acquisition Corp. He was previously CEO of the pharmaceutical company Allergan.  In this conversation, we discuss Allergan, building a $80+ billion business, growing through M&A, The Beauty Health Company, bitcoin, crypto, and Brent tells some amazing stories.  ======================= Polymarket is the world's leading information markets platform where you can trade on the most pressing global questions and see unbiased, real-time data on what the market thinks will happen – all on the blockchain. For a limited time, sign up with referral code “Pomp” to get your first trade reimbursed up to $100. Click on the link to get started: polymarket.co/pomppod ======================= Cosmos is building the Internet of Blockchains, marking a new era of interoperability, scalability, and usability. The free flow of assets and data between blockchains with bridges to Ethereum and Bitcoin will unleash the potential of DeFi, NFTs, and much more. Dive into Cosmos at cosmos.network/pomp  ======================= Matrixport, Asia's fastest growing digital asset platform with $10 billion in assets under management and custody, it offers one-stop crypto financial solutions including fixed income, DeFi in 1-click, structured products, Cactus Custody™, spot OTC as well as lending. You can earn from high single digit with fixed income to high double digit yield with their Dual Currency Product. If you hold crypto and look for yield, this is the app you don't wanna miss out. Go download the Matrixport App and enjoy a welcome offer of 30% APY on USDC here: https://invest.matrixport.com/en

The Dow gained 237 points today and Jim Cramer's making sure you're set up for next week with his Gameplan. Then, former chairman and CEO of Allergen, Brent Saunders joins Cramer to talk about his new role as the Executive Chairman of Beauty Health Co. And, as Nike stock soars higher after earnings, Cramer's breaking down the company's report and what he took away from the quarter. Plus, Cramer's taking your calls in this week's edition of Am I Diversified?

I'm so excited to welcome former CEO & Chairman of Allergan, Brent Saunders, onto the podcast today! As an industry leader in aesthetics and pharmaceuticals, he has great insight for aspiring entrepreneurs. He is also the founder & chairman of a new business venture, Vesper Health. In this episode we talk about: What a SPAC company is & why he decided to build one during COVID The challenges of breeding innovation in large corporations and fostering company culture What a typical day in the office looked like as the CEO of Allergan  Things he swears by in business and advice he wishes he received when first starting out  His professional journey to where he is today To follow Brent Saunders on Instagram, find him @brentlsaunders.  Submit your questions for the podcast to Dr. Azi on Instagram @skinbydrazi, on YouTube and on Tik Tok @skinbydrazi. Shop skincare at AziMDSkincare.com and learn more about the practice at LaJollaLaserDerm.com. The content of this podcast is for entertainment, educational and informational purposes and does not constitute formal medical advice. © Azadeh Shirazi, MD, FAAD.

On today’s podcast, we welcome special guest Clint Carnell, CEO of The HydraFacial Company, a category-creating beauty health company. HydraFacial recently announced a merger with SPAC Vesper Healthcare Acquisition in a $1.1 billion deal.  On the podcast, Clint discusses: -The main appeal of the healthcare industry and the aesthetics segment specifically -Details behind HydraFacial’s “razors + razorblades” business model -Surviving the pandemic as a PE-backed company -Why he chose Vesper founder Brent Saunders as a partner in their SPAC merger -Global growth opportunities available to HydraFacial -And more

The Compliance Life details the journey to and in the role of a Chief Compliance Officer. How does one come to sit in the CCO chair? What are some of the skills a CCO needs to success navigate the compliance waters in any company? What are some of the top challenges CCOs have faced and how did they meet them? These questions and many others will be explored in this new podcast series. Over four episodes each month on The Compliance Life, I visit with one current or former CCO to explore their journey to the CCO chair. This month, my guest is Jonathan Kellerman, Partner at StoneTurn and former CCO at Allergan.  When Coopers merged with PriceWaterhouse to form PwC, Kellerman continued his health care consulting work. He worked under John Dugan, a health care industry, compliance veteran. While at PwC, he launched two industry leading global advisory practices for compliance management in health care, pharmaceuticals and life sciences. He also worked with Brent Saunders, another health care industry, compliance veteran. Resources  Jonathan Kellerman LinkedIn Profile Jonathan Kellerman StoneTurn Profile StoneTurn Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode gives you the scoop on the 7 signs of a strong brand! Your host Casey Lemieux talks with Brent Saunders, host of the Providing More Podcast, about all the different things that help make your branding strong and stand out. This episode is for anyone trying to build their brand on social media! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/the-social-media-scoop/support

Today we've got a great interview with the CEO of Vesper Healthcare Acquisition Corp. and former CEO of Allergan, Forest Laboratories, and Bausch + Loam Inc, Brent Saunders, about the vaccine. Then we're discussing Apple's new over-the-ear headphones, Moncler's $1.4 billion purchase of Stone Island Sportswear, the motor chief of Nikola's $32.5 million purchase of land in Utah, streaming's impact on Nielsen TV ratings, As Seen on Social, and more. The biggest award show of the year! The 2020 Group Chat Awards LIVE on Twitch December 14th @ 8PM (PST) - Giveaways, special guests, entrainment and more! Mark your calendars www.twitch.tv/groupchatpod Group Chat University, our debut collegiate merch is here! We collaborated with Melrose Place to bring you the best quality merch we could get our hands on. Orders are open for one week, when it’s gone it’s gone! https://www.themenlohouse.com/store/collection/group-chat  28 Days from Freedom – Group Chat News A great interview with return guest, the CEO of Vesper Healthcare Acquisition Corp., Brent Saunders. They discuss all things related to the COVID-19 vaccine, tech talent living away from Silicon Valley, his take on breaking medical news & MUCH MORE! [3:11] Pete Reads the Ads. [47:52] How our public officials have failed us. [52:21] Apple has balls of steel! [55:52] A tale of two companies: Moncler and Nikola, what is considered a success? [1:06:00] Why you should be fired if you’re an advertiser who follows the Nielson ratings. [1:13:30] As Seen on Social. [1:16:08] Group Chat Shout Outs. [1:23:48] Related Links/Products Mentioned Apple to Sell AirPods Max Over-the-Ear Headphones for $549 Moncler Buys Stone Island Sportswear Brand for $1.4 Billion Nikola Motor Chief Sets Utah Real Estate Record With $32.5 Million Buy Jared Kushner and Ivanka Trump are moving to Indian Creek Island. Meet their neighbors Nielsen Sets Timeline for Big Change in TV Ratings Bill Simmons on the Harden Fiasco, Teams He’s High and Low on, Rookie of the Year Picks, and More NBA Memo Says Coaches Must Wear Masks in Arenas, Team Facilities Amid Pandemic How Ohio State vs. Michigan cancellation impacts Buckeyes' Big Ten championship, CFP hopes in 2020 Logan Paul's Orthopedic Surgeon Vs. Floyd Mayweather – Modern Prescription Connect with Group Chat! Watch The Pod #1 Newsletter In The World For The Gram Tweet With Us Exclusive Facebook Content    

Brent Saunders has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. Until May 2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63 billion, Mr. Saunders served as Chairman, President and Chief Executive Officer of Allergan plc. His role as President and Chief Executive Officer of Allergan began in July 2014 and his added role of Chairman began in October 2016. Mr. Saunders first role as an executive officer in the pharmaceuticals and healthcare sectors began in 2003, as a member of the executive management team at Schering-Plough Corporation, where he held several key roles, including President of the company’s Global Consumer Health Care division. While at Schering-Plough, Mr. Saunders led the integrations of the company’s $14 billion acquisition of Organon Biosciences N.V in 2007 as well as the merger between Schering-Plough and Merck & Co., Inc. in 2009. From March 2010 until August 2013, Mr. Saunders served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, until its acquisition by Valeant Pharmaceuticals, Inc. in 2013. He then became the Chief Executive Officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis plc in 2014. Following the merger with Actavis, Mr. Saunders was named Chief Executive Officer of the combined business. In 2015, he led Actavis’ acquisition of Allergan, renaming the combined company Allergan Plc. Learn more about Vesper Health: https://www.vesperhealth.com/ Follow Brent Saunders on Instagram: https://www.instagram.com/brentlsaunders/?hl=en Follow Brent Saunders on Twitter: https://twitter.com/brentlsaunders - Follow me on Instagram: https://instagram.com/casey

Hi friends! Today is about failures. I'm joined by my wonderful husband to talk about our mistakes and how we've learned from them. Let's have a crazy dog chat!

In this episode, Brent Saunders talks with Tommy Choi, a Realtor in Chicago, Illinois. Tommy is ranked in the Top 1% of realtors by the Chicago Association of Realtors. He and his team have appeared on HGTV House Hunters and House Hunters Renovation. In this episode he explains how 90% of his business comes from his referral network!

Today we're interviewing Brent Saunders-- former CEO of both Allergan and Bausch + Lomb, then we're discussing the NFL teams that are shutting down as a result of COVID-19, the cities that are giving their citizens cash, Trump's history of tax evasion and financial losses, Biden's $300,000 tax payment in 2019, Trump's alleged mocking of his Christian supporters, the Christian group that raised $500,000 for the legal defense of Kyle Rittenhouse, Charlotte Kirk's nonconsensual sex allegations against Kevin Tsujihara, BTS's highly successful IPO, Bryce Hall's new finance podcast, Him's consideration of going public via Oaktree SPAC, Warren Buffett's stake in Snowflake and its $800 million gain, As Seen on Social, and more. The best shoe you’ll ever purchase! Use code ‘KATHY’ at shopnewrepublic.com for $10 off your whole order! Dee's Taking the Vaccine – Group Chat News An interview with Brent Saunders, former CEO of both Allergen and Bausch + Lomb. He discusses the idea of ‘capitalistic compassion’, how we should be looking at the vaccine, the COVD-19 impact on the economy & MUCH MORE! [2:22] Is this the beginning of the end for the NFL? [34:35] The Universal Basic Income city experiment. [40:35] What’s the deal with Trump’s taxes?! [45:29] Trump, not so holy? [55:13] Pete Reads the Ads. [1:00:35] A Christian group is here to help Kyle Rittenhouse. [1:04:37] Who in the world is Charlotte Kirk?! [1:07:30] How the stock market has now become the brand market. [1:16:40] TikTok’s Bryce Hall has entered the podcast space. [1:19:20] The latest news in IPO Land. [1:23:50] As Seen on Social. [1:27:07] Group Chat Shout Outs. [1:31:58] Related Links/Products Mentioned IG: @brentlsaunders Two NFL Teams Shut Down as the Tennessee Titans Face a Covid-19 Outbreak Cities Experiment With Remedy for Poverty: Cash, No Strings Attached LONG-CONCEALED RECORDS SHOW TRUMP’S CHRONIC LOSSES AND YEARS OF TAX AVOIDANCE Trump Declines to Say How Much He Has Paid in Federal Income Taxes Bidens Release 2019 Returns, Paid Nearly $300,000 In Taxes Trump Secretly Mocks His Christian Supporters Donald Trump unable to name one verse from "favorite book" The Bible Christian Group Raises More Than $500,000 for Kyle Rittenhouse's Legal Defense Charlotte Kirk, Kevin Tsujihara and a Nonconsensual Sex Allegation That Sparked a Secret Legal Saga Big Hit IPO makes BTS millionaires and their producer a billionaire TikTok's Bryce Hall Launches Finance Podcast Capital University: I 'Thought Money Was an Object' Startup Hims Nears a Deal to Go Public Via Oaktree SPAC Warren Buffett's Berkshire Hathaway discloses Snowflake stake, confirming a rapid $800 million gain Pierce Brosnan Lists James Bond–Inspired Malibu Estate Coinbase CEO Brian Armstrong Clarifies that Digital Asset Exchange Is “Laser-Focused” on Achieving “Sustained High Performance” Connect with Group Chat! Watch The Pod #1 Newsletter In The World For The Gram Tweet With Us Exclusive Facebook Content

What’s the deal with title insurance? Brent Saunders, the Business Development Manager for PM Title in Columbus, Ohio, breaks down the difference between standard and enhanced title insurance and why you need it. Listen in to hear the stories of when he got chased off church property and awkwardly stuck between a fighting husband and wife. Please subscribe to this podcast in iTunes or in the Podcasts App on your phone, and never miss a beat from Leigh by visiting leighbrown.com. If you’re tired of doing real estate alone, enroll in Leigh Brown University and be sure to use your special “CSIRE” discount code at checkout for $10 off your subscription. Time Stamped Show Notes 01:00 – Introducing Brent, the Business Development Manager for PM Title in Columbus, Ohio - the fastest-growing title company in Ohio since 2015 01:15 - They help agents and have a videography team, a social media team, a podcast, and more 02:10 - Agents don’t have to disclose how they leverage their vendors and resources; he’s okay with agents taking all the credit 04:30 – Standard vs. enhanced title insurance 04:48 - There are three basic formed of title insurance: lender’s policy, homeowner’s policy, and an owner’s policy 05:00 - You pay a premium in case there’s a problem like any other insurance product, but it also covers any problems that have already happened 05:50 - Lenders typically require a lender’s policy to protect their assets and investment 06:20 - Owner’s and homeowner’s policies protect against a claim; in the Columbus market, they require the enhanced policy 07:00 - The enhanced policy is 15% more expensive and appreciates with the property 08:00 – On getting an enhanced policy if you already have a standard one 08:15 - He’s not sure if you can switch; he’ll ask his attorney 08:50 – Brent’s CRIRE story 09:10 - 3 years ago, they hired their first videographer; an agent needed a video of a church that was a total wreck 09:45 - They couldn’t get into the property and tried the back door; the next-door people started screaming at them 10:30 - A guy comes out and starts screaming at them, calling them slum lords, and saying their kids keep getting hurt on the roof 10:50 - They let their 100-pound dog out; they decided just to do exterior shots and leave 11:50 – Lessons 12:10 - Protect yourself and your staff. Photo/video isn’t worth your safety 12:30 – Another CSIRE story 12:35 - Dower Law: When you get married, your spouse owns an interest in your property 13:20 - You can’t buy or sell a property without your spouse’s signature in some states 13:40 - He had a client who said his wife was going to show up to sign off on something; when she shows up, they start getting into an argument 13:55 - She said she wasn’t going to sign, they went back and forth; she brought legal documents, too, and asked him to sign hers and she would sign his 15:00 - Brent didn’t ask and didn’t want to know what her documents were all about 15:10 – Lessons 15:15 - It’s awkward to be in the middle of a couple fighting 15:40 - Don’t get in the middle of a couple’s fight and don’t be nosey 16:30 - Maybe your dog could protect you when you’re out and about 17:00 – How to reach Brent: the PM Title website; they are connectors, happy to help, and go above and beyond  3 Key Points Leverage your resources!  Protect yourself. Don’t get in the middle of a spousal fight!

Your Network is your Net-worth!! In this episode, Brent Saunders talks with Daniel Askew, a realtor from Nashville, TN. Daniel used his exceptional networking skills to build a massive database and become a referral superstar!!

In this episode, Brent Saunders talks with Leigh Brown, a Realtor in Charlotte, NC. Leigh and her team were ranked on the top 200 list by Real Trends and Wall Street Journal as one of the Top Real Estate professionals and teams.

In this episode, Brent Saunders talks with Karen Briscoe, who's team has sold over 1500 homes valued at over 1.5 Billion Dollars! In 2016, she wrote the book Real Estate Success in 5 Minutes a Day!

In this episode, Brent Saunders talks with Karen Carr, an agent from Savannah, GA that leveraged the power of Youtube to help her business skyrocket!!

In this episode of Providing More, Brent Saunders talks with Denver, CO Real Estate Agent and President of the Denver Tesla Club, Sean Michael Mitchell! Learn more about how to leverage your passions to grow your real estate business!

Negotiations in Real Estate is essential! In this episode, Brent Saunders talks with Kwame Christian. Bestselling author and speaker, Kwame Christian is the Director of the American Negotiation Institute and a subject matter expert in the field of negotiation and conflict resolution.

Brent Saunders and Brian Teyssier discuss building success as a realtor through branding, social media, and more! Brian is the most positively reviewed Zillow Realtor in ALL of Pennsylvania.

Brent Saunders and Keri Shull dig down to the roots of how Keri grew her business to be #33 in the COUNTRY! Keri Shull is the co founder of the Keri Shull Team, the top selling real estate team in the Washington DC, Maryland, and Virginia area. She is also the co founder of HyperFast Agent and is offering an AMAZING product for agents everywhere.

Brent Saunders and Nick Good discuss the prospecting system that contributed to Nick's success in Dallas, Texas.Nick's Website: https://www.thegoodhometeam.com/Nick's Podcast: https://www.realnewscn.com/the-only-real-estate-podcast-worth-listening-to/

Brent Saunders and Nick Good discuss how to overcome objections and continue to provide value.Nick's Website: https://www.thegoodhometeam.com/Nick's Podcast: https://www.realnewscn.com/the-only-real-estate-podcast-worth-listening-to/

We bring to you a discussion on Negligence in a Real Estate Transaction. Brent Saunders from PM Title joined our party of 2, to make 3, and discuss how does negligence sometimes factor in to the transaction.

Brent Saunders with PM Title joined the podcast to discuss the growth happening in the Cbus and surrounding areas.

This week, Caroline Hyde sat down with Allergan Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a "huge" pay cut and what's coming next for him after the AbbVie deal.

Happy Tuesday, Beauty Byters!Today is finally the day! I’m so excited to share with all of you this very special episode of Beauty Bytes with Dr. Kay: Secrets of a Plastic Surgeon. On December 13th, I had the honor of welcoming Brent Saunders, CEO and chairman of the board of Allergan to my office. Allergan is the maker of injectables such as Botox and Juvederm, as well as products like Latisse and Skin Medica Skincare. Brent and I touch on subjects like aging in the digital age, the future of the aesthetics industry, mental health, and Spotlyte –– Allergan’s new digital hub. We discuss a longer lasting and faster acting Botox, the one thing this Fortune 500 CEO never misses in his skincare routine, and he even tells us about some of the injectables he’s tries himself! I have such a respect for how ambitious, insightful, and cutting edge Brent is while remaining humble. I am very delighted to introduce my listeners to this total boss guy and I hope you all enjoy this very special episode of Beauty Bytes with Dr. Kay: Secrets of a Plastic Surgeon! Stay beautiful!

Happy Tuesday, Beauty Byters! Today is finally the day! I’m so excited to share with all of you this very special episode of Beauty Bytes with Dr. Kay: Secrets of a Plastic Surgeon. On December 13th, I had the honor of welcoming Brent Saunders, CEO and chairman of the board of Allergan to my office. Allergan is the maker of injectables such as Botox and Juvederm, as well as products like Latisse and Skin Medica Skincare. Brent and I touch on subjects like aging in the digital age, the future of the aesthetics industry, mental health, and Spotlyte –– Allergan’s new digital hub. We discuss a longer lasting and faster acting Botox, the one thing this Fortune 500 CEO never misses in his skincare routine, and he even tells us about some of the injectables he’s tries himself! I have such a respect for how ambitious, insightful, and cutting edge Brent is while remaining humble. I am very delighted to introduce my listeners to this total boss guy and I hope you all enjoy this very special episode of Beauty Bytes with Dr. Kay: Secrets of a Plastic Surgeon! Stay beautiful!

Listen to any earnings call on demand with the Borsa Earnings Call mobile app on the App Store. Download here: itunes.apple.com/us/app/borsa-earnings-calls/id1414117603?mt=8 Welcome to Earnings Season. Our goal is to make listening to earnings calls easier. So I will be uploading relevant and newsworthy earnings calls for easy listening. To request a company's earnings call, email borsaHQ@gmail.com. This podcast episode is Allergan's 2018 Q2 earnings call. Listen to Brent Saunders and other Allergan executives discuss their company's performance. About Earnings Season: Earnings Season posts relevant earnings calls for an easy listening experience. To request a company for us to post earnings calls for, email borsahq@gmail.com.

Episode 86: No matter that the Los Angeles Ports moves 40 percent of the containerized goods entering the country, generating billions of dollars in commerce—it’s rip-off time when it comes to treating the truck drivers and warehouse workers fairly. I know, you’re shocked! I recently checked out a big rally, featuring Bernie Sanders, by workers trying to form a union at a number of companies at the L.A. ports. In the big picture, the workers are getting screwed like a lot of workers: companies misclassify workers, treating them as independent contractors, not employees. After you hear segments from the energetic rally, I chat with truck driver Daniel “Seko” Uaina. I, then, talk with progressive candidate Kara Eastman who won the Democratic primary for the 2nd Congressional District in Nebraska—and, then, got the blow-off from the national party, at least partly because she defeated the favored centrist “Blue Dog.” Because the national party has been so-skilled at winning elections, rights? Our Robber Baron of the week is the CEO of Allergan, Brent Saunders.

Brent Saunders, president, CEO, and chairman of global leader Allergan, sits down at OIS@AAO to discuss what impact the pending loss of the Restasis patent could have on the company. He also rejects talk of Allergan breaking off its ophthalmology business, saying the company is in the sector to stay.

In 2011, Cal Roberts, MD, got an unexpected call from Brent Saunders, then head of Bausch & Lomb. Saunders asked if Dr. Roberts would trade a thriving ophthalmology practice to serve as chief medical officer at the eye care giant. Today, Dr. Roberts is thrilled with the decision, and other ophthalmology companies are following the example, bringing on practicing physicians as CMOs. But what were Dr. Roberts’ concerns? And why did he decide to take the leap? “It’s difficult and it’s sometimes more difficult than someone coming in realizes,” he says.

Hear from Allergan’s Past and Future: Highlights of interviews with Brent Saunders and Gavin Herbert.